Search Results 921-930 of 25604 for treatment resistant depression
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas · Overview · Participation eligibility.
Breathing or lung problems (eg, COPD, hypoxia, sleep apnea) or; Cor pulmonale (serious heart condition) or; Depression, history of or; Drug dependence, ...
The purpose of this study is to evaluate the safety, clinical pharmacology and clinical activity of TNB-383B, a T-cell engaging bispecific antibody, in subjects ...
The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) ...
Lorelei S. Rowe, Ph.D., L.P.. Psychologist. Rochester, MN. Areas of focus: Cognitive behavioral therapy, Psychotherapy, Depression ...
Sleep terrors may need treatment if they cause problems with getting enough sleep or cause a safety risk. ... Mood disorders, such as depression and anxiety.
A Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma. Print details. Share; Facebook ...
Explain that depression is a complex condition — not a personal flaw or weakness — and that effective treatment exists. Suggest seeking help from a health care ...
The purpose of this study is to allow JBPOS0101 (investigational product) to be given as either add-on therapy or monotherapy for patients with refractory ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.